Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novartis designs novel IL-12RB1-targeted antibodies

May 2, 2012

Research at Merck & Co. yields novel candidate hepatitis C therapies

May 2, 2012

New motilin receptor agonists divulged by Daiichi Sankyo

May 2, 2012

New diacylglycerol O-acyltransferase 1 inhibitors designed

May 2, 2012

Kissei Pharmaceutical patents new indolizine derivatives

April 30, 2012

New monoamine reuptake inhibitors discovered in China

April 30, 2012

Proximagen designs novel chemokine CCR2 receptor antagonists

April 30, 2012

Almirall presents new SYK/JAK inhibitors

April 30, 2012

Novel telomerase inhibitors developed at Pharminox

April 30, 2012

German university announces novel candidate analgesics

April 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...